Pages that link to "Item:Q2001894"
From MaRDI portal
The following pages link to Predicting overall vaccine efficacy in a new setting by re-calibrating baseline covariate and intermediate response endpoint effect modifiers of type-specific vaccine efficacy (Q2001894):
Displaying 3 items.
- Evaluating principal surrogate markers in vaccine trials in the presence of multiphase sampling (Q3119801) (← links)
- Causal inference methods for vaccine sieve analysis with effect modification (Q6626807) (← links)
- Incorporating baseline covariates to validate surrogate endpoints with a constant biomarker under control arm (Q6628202) (← links)